Denali Therapeutics Inc. · NASDAQ:DNLI

Denali Therapeutics Inc. shareholders

As of Sep 30, 2026, 275 institutions reported holding Denali Therapeutics Inc., 95.1% of its shares. Largest: T. Rowe Price, Vanguard and BlackRock. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Denali Therapeutics Inc.ChangeFiled
T. Rowe Price22.6M14.1%+3.26MNov 16, 2026
Vanguard14.8M9.2%+822KNov 16, 2026
BlackRock14.3M8.9%+302KNov 13, 2026
Baillie Gifford & Co11.1M6.9%−840KNov 9, 2026
Temasek Holdings (Private) Ltd7.01M4.4%no changeOct 28, 2026
State Street6.68M4.2%−367KNov 12, 2026
UBS5.75M3.6%−528KNov 16, 2026
Fidelity4.53M2.8%−2,715Nov 10, 2026
Geode Capital4.04M2.5%+65,478Nov 6, 2026
Goldman Sachs3.75M2.3%−401KNov 16, 2026

Denali Therapeutics Inc. insider trades